Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | IMNM | IMMUNOME INC | Healthcare | 20,000.0 | $437K | 0.31% | -5K | -20.8% | $21.87 | +26.1% |
| 42 | — | KINIKSA PHARMACEUTICALS INTL | — | 9,000.0 | $433K | 0.31% | -4K | -28.9% | $48.15 | — |
| 43 | TGTX | TG THERAPEUTICS INC | Healthcare | 13,000.0 | $432K | 0.31% | -5K | -27.0% | $33.22 | +62.3% |
| 44 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 5,000.0 | $420K | 0.30% | -8K | -60.7% | $83.92 | +26.1% |
| 45 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 13,000.0 | $412K | 0.29% | -7K | -36.2% | $31.72 | +23.3% |
| 46 | PTCT | PTC THERAPEUTICS INC | Healthcare | 6,000.0 | $409K | 0.29% | -1K | -14.8% | $68.13 | +2.9% |
| 47 | VERA | VERA THERAPEUTICS INC | Healthcare | 10,000.0 | $402K | 0.28% | — | — | $40.23 | -15.0% |
| 48 | HRMY | HARMONY BIOSCIENCES HLDGS IN | Healthcare | 14,283.0 | $400K | 0.28% | — | — | $28.01 | +40.0% |
| 49 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 11,000.0 | $400K | 0.28% | -316.0 | -2.8% | $36.32 | +133.6% |
| 50 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 71,000.0 | $393K | 0.28% | NEW | — | $5.53 | +148.3% |
| 51 | STOK | STOKE THERAPEUTICS INC | Healthcare | 12,000.0 | $391K | 0.28% | -5K | -27.8% | $32.56 | -2.9% |
| 52 | KOD | KODIAK SCIENCES INC | Healthcare | 10,000.0 | $381K | 0.27% | -9K | -48.5% | $38.12 | -1.0% |
| 53 | DYN | DYNE THERAPEUTICS INC | Healthcare | 20,000.0 | $363K | 0.26% | -2K | -7.1% | $18.13 | +38.3% |
| 54 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 30,000.0 | $358K | 0.25% | NEW | — | $11.93 | +40.7% |
| 55 | NTLA | INTELLIA THERAPEUTICS INC | Healthcare | 26,900.0 | $345K | 0.24% | NEW | — | $12.82 | +0.4% |
| 56 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 3,000.0 | $316K | 0.22% | -3K | -51.0% | $105.40 | +36.9% |
| 57 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 600.0 | $314K | 0.22% | -292.0 | -32.7% | $523.47 | +2.0% |
| 58 | SUPN | SUPERNUS PHARMACEUTICALS | Healthcare | 6,000.0 | $310K | 0.22% | -5K | -44.2% | $51.69 | -15.4% |
| 59 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 14,400.0 | $301K | 0.21% | NEW | — | $20.92 | +11.6% |
| 60 | ERAS | ERASCA INC | Healthcare | 17,327.0 | $280K | 0.20% | NEW | — | $16.18 | +11.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%